Regulation of pancreatic ductal adenocarcinoma progression by Hnf4a
Hnf4a 对胰腺导管腺癌进展的调节
基本信息
- 批准号:9063112
- 负责人:
- 金额:$ 15.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-04 至 2017-04-30
- 项目状态:已结题
- 来源:
- 关键词:AdenocarcinomaAdenocarcinoma CellAdoptedAgonistAnchorage-Independent GrowthBiological ProcessCell LineCellsComplementary DNADataDevelopmentDifferentiation and GrowthDiseaseEpithelial CellsExhibitsFutureGastrointestinal tract structureGenesGeneticGenetically Engineered MouseGoalsGrowthHealthHomeostasisHumanImmunohistochemistryIn SituInflammationInvestigationLesionLiverLung AdenocarcinomaMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of lungMalignant neoplasm of pancreasMeasuresMetabolismModelingMolecularMucinousMusNeoplasmsNormal tissue morphologyNuclear ReceptorsOncogenicPancreasPancreatic Ductal AdenocarcinomaPancreatic Intraepithelial NeoplasiaPathway interactionsPlayPrimitive foregut structureRNA InterferenceRegulationRoleSpecific qualifier valueStagingTestingTherapeuticTissuesTranscriptWell Differentiated Lesionbasecancer typedesigngastrointestinalknowledge translationmalignant statemouse modelnovel therapeutic interventionnovel therapeuticsoverexpressionpancreatic neoplasmpreclinical studyresponsesmall moleculetranscription factortranscriptome sequencingtumortumor initiationtumor progression
项目摘要
DESCRIPTION (provided by applicant): The molecular networks that specify cellular identity and suppress alternative cell fates are tightly regulated during normal tissue homeostasis but can become dramatically dysregulated during cancer progression. It has long been appreciated that tumor differentiation state often correlates with both intrinsic malignant potential and response to therapy. However, the master transcriptional regulators that control cellular identity in most cancer types remain to be elucidated. The long-term goal of this project is to determine how changes in cellular identity contribute to the progression of pancreatic ductal adenocarcinoma (PDAC). Pancreatic neoplasia adopts a foregut-like differentiation state that is distinct from normal pancreatic epithelial cells. We have observed that the differentiation state o pancreatic in situ neoplasia (PanIN) closely resembles that of mucinous lung adenocarcinoma, a type of lung cancer that also exhibits a foregut-like differentiation state. One of the foregut-associated transcripts expressed in both types of neoplasia is Hnf4α, a transcription factor that normally regulates the differentiation state of the gastrointestinal tract and liver. Using conditional murine genetics, we demonstrated that Hnf4α is a critical regulator of the growth and differentiation state of mucinous lung adenocarcinoma. In this proposal, we will test the hypothesis that Hnf4α regulates the differentiation state and malignant progression of pancreatic ductal adenocarcinoma using the following specific aims: (1) Determine the impact of Hnf4α loss on the differentiation and malignant progression of pancreatic ductal adenocarcinoma and (2) Characterize the mechanisms by which Hnf4α regulates the growth and differentiation state of pancreatic ductal adenocarcinoma.
描述(由申请人提供):指定细胞身份和抑制可供选择的细胞命运的分子网络在正常组织动态平衡期间受到严格调控,但在癌症进展过程中可能变得严重失调。长期以来,人们一直认为肿瘤分化状态往往与固有的恶性潜能和对治疗的反应有关。然而,在大多数癌症类型中控制细胞特性的主要转录调控因子仍有待阐明。该项目的长期目标是确定细胞特性的变化如何有助于胰腺导管腺癌(PDAC)的进展。胰腺肿瘤呈现一种不同于正常胰腺上皮细胞的前肠样分化状态。我们观察到胰腺原位瘤(Panin)的分化状态与粘液性肺腺癌非常相似,粘液性肺腺癌是一种也表现出前肠样分化状态的肺癌。在两种类型的肿瘤中表达的前肠相关转录本之一是HNF4α,这是一种转录因子,通常调节胃肠道和肝脏的分化状态。利用条件小鼠遗传学方法,我们证明了HNF4α是粘液性肺腺癌生长和分化状态的关键调节因子。在本研究中,我们将从以下几个方面对HNF4α调控胰腺癌分化状态和恶性进展的假说进行验证:(1)确定HNF4α缺失对胰腺癌分化和恶性进展的影响;(2)研究HNF4α调控胰腺导管腺癌生长和分化状态的机制。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric Lee Snyder其他文献
Eric Lee Snyder的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric Lee Snyder', 18)}}的其他基金
Lineage specifiers governing pancreatic cancer growth and molecular subtype
控制胰腺癌生长和分子亚型的谱系说明符
- 批准号:
10164735 - 财政年份:2020
- 资助金额:
$ 15.35万 - 项目类别:
Lineage specifiers governing pancreatic cancer growth and molecular subtype
控制胰腺癌生长和分子亚型的谱系说明符
- 批准号:
10400085 - 财政年份:2020
- 资助金额:
$ 15.35万 - 项目类别:
Lineage specifiers governing pancreatic cancer growth and molecular subtype
控制胰腺癌生长和分子亚型的谱系说明符
- 批准号:
10681598 - 财政年份:2020
- 资助金额:
$ 15.35万 - 项目类别:
Lineage Specifiers Governing Pancreatic Cancer Growth and Molecular Subtype
控制胰腺癌生长和分子亚型的谱系说明符
- 批准号:
10504285 - 财政年份:2020
- 资助金额:
$ 15.35万 - 项目类别:
Lineage specifiers governing pancreatic cancer growth and molecular subtype
控制胰腺癌生长和分子亚型的谱系说明符
- 批准号:
10621759 - 财政年份:2020
- 资助金额:
$ 15.35万 - 项目类别:
Lineage specifiers governing pancreatic cancer growth and molecular subtype
控制胰腺癌生长和分子亚型的谱系说明符
- 批准号:
10738018 - 财政年份:2020
- 资助金额:
$ 15.35万 - 项目类别:
Transcriptional Regulation of Lung Cancer Identity
肺癌身份的转录调控
- 批准号:
10583302 - 财政年份:2017
- 资助金额:
$ 15.35万 - 项目类别:
Transcriptional Regulation of Lung Cancer Identity
肺癌身份的转录调控
- 批准号:
10330897 - 财政年份:2017
- 资助金额:
$ 15.35万 - 项目类别:
Regulation of pancreatic ductal adenocarcinoma progression by Hnf4a
Hnf4a 对胰腺导管腺癌进展的调节
- 批准号:
9112399 - 财政年份:2015
- 资助金额:
$ 15.35万 - 项目类别:
相似海外基金
Assessing The Impact of Heparanase and NDST2 Expression on Non-Small Cell Lung Adenocarcinoma Cell Motility
评估乙酰肝素酶和 NDST2 表达对非小细胞肺腺癌细胞运动的影响
- 批准号:
449570 - 财政年份:2020
- 资助金额:
$ 15.35万 - 项目类别:
Studentship Programs
Analysis of cancer metastasis and invasion mechanism using a new lung adenocarcinoma cell line.
使用新的肺腺癌细胞系分析癌症转移和侵袭机制。
- 批准号:
16K10689 - 财政年份:2016
- 资助金额:
$ 15.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Acquisition strategy of tumor-specific markers using established micropapillary pattern pulmonary adenocarcinoma cell line
使用已建立的微乳头模式肺腺癌细胞系获取肿瘤特异性标志物的策略
- 批准号:
26460441 - 财政年份:2014
- 资助金额:
$ 15.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The antibetic drug metformin inhibits esophageal adenocarcinoma cell proliferation in vitro and in vivo.
抗生素药物二甲双胍在体外和体内抑制食管腺癌细胞增殖。
- 批准号:
25860540 - 财政年份:2013
- 资助金额:
$ 15.35万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
The cell permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferations and can be used as the molecular targeting dru
细胞通透肽抑制胰腺导管腺癌细胞增殖,可作为分子靶向药物
- 批准号:
25461969 - 财政年份:2013
- 资助金额:
$ 15.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Basic Research for elucidation of chemo-resistance in mucinous adenocarcinoma cell.
阐明粘液腺癌细胞化疗耐药性的基础研究。
- 批准号:
22791532 - 财政年份:2010
- 资助金额:
$ 15.35万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
TAS::75 0849::TAS IN THIS PHASE I SBIR THE BREAST CANCER ADENOCARCINOMA CELL LI
TAS::75 0849::TAS 在这一阶段 I SBIR 乳腺癌腺癌细胞 LI
- 批准号:
8164743 - 财政年份:2010
- 资助金额:
$ 15.35万 - 项目类别:
Role of Endothelin-1 in osteoblastic bone metastasis produced by a human lung adenocarcinoma cell line
Endothelin-1 在人肺腺癌细胞系产生的成骨细胞骨转移中的作用
- 批准号:
19790127 - 财政年份:2007
- 资助金额:
$ 15.35万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
CONNEXIN 43 EXPRESSION IN ADENOCARCINOMA CELL LINE
连接蛋白 43 在腺癌细胞系中的表达
- 批准号:
6972483 - 财政年份:2004
- 资助金额:
$ 15.35万 - 项目类别:
The mechanisms of highly metastetic capasity in highly metastatic subpopulations of lung adenocarcinoma cell line and these clinical applications
肺腺癌细胞系高转移亚群的高转移能力机制及临床应用
- 批准号:
15590831 - 财政年份:2003
- 资助金额:
$ 15.35万 - 项目类别:
Grant-in-Aid for Scientific Research (C)